Overall, this non-exhaustive collection of studies shows that AhR activation promotes tumor progression in various types of cancer and that the immunosuppressive properties of the kynurenine-activated AhR constitutes a highly promising axis for cancer treatment [39,49]. The gene discussed is AHR; the disease is cancer.